Samsung Biologics saw the highest growth of 7.99% in patent filings in May and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Samsung Biologics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Samsung Biologics has been focused on protecting inventions in South Korea(KR) with five publications in Q2 2024
The South Korea(KR) Patent Office dominates the patent filings with nearly 56% of filings. The South Korea(KR), World Intellectual Property Organization(WIPO), Denmark(DK), and European Patent Office(EPO) patent Office are among the top ten patent offices where Samsung Biologics is filings its patents. Among the top granted patent authorities, Samsung Biologics has 50% of its grants in European Patent Office(EPO) and 50% in Poland(PL).
Roche and Johnson & Johnson could be the strongest competitors for Samsung Biologics
Patents related to cell & gene therapy lead Samsung Biologics's portfolio
Samsung Biologics has the highest number of patents in cell & gene therapy. For cell & gene therapy, nearly 100% of patents were filed and no patents were granted in Q2 2024.
For comprehensive analysis of Samsung Biologics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
